Literature DB >> 6727935

Cardiac rhythm after the Mustard operation for complete transposition of the great arteries.

C J Flinn, G S Wolff, M Dick, R M Campbell, G Borkat, A Casta, A Hordof, T J Hougen, R E Kavey, J Kugler.   

Abstract

The Mustard operation corrects the effects of congenital transposition of the great arteries by creating an intraarterial baffle to direct pulmonary venous blood to the tricuspid orifice and systemic venous blood to the mitral orifice. To identify the long-term effects of this procedure, we followed 372 patients with complete transposition of the great arteries who survived the Mustard operation for at least three months. The mean follow-up period was 4.5 years (range, 0.4 to 15.9); the mean age at operation was 2.0 years. Mean resting heart rates were consistently lower than those for age-matched normal children. Seventy-six per cent of the patients had sinus rhythm during the year of operation--a figure that decreased to 57 per cent by the end of the eighth postoperative year. Twenty-five patients died during the follow-up period, nine suddenly. Life-table analysis revealed a cumulative survival rate of 91 per cent for 11 years and 71 per cent for 15 years after the operation. No strong risk factor for sudden unexpected death identified. This study demonstrates that extended survival among patients with transposition can be expected after the Mustard operation. However, over time there is a decreasing prevalence of normal sinus rhythm in survivors, as well as a small risk of sudden death.

Entities:  

Mesh:

Year:  1984        PMID: 6727935     DOI: 10.1056/NEJM198406213102504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  18 in total

Review 1.  A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease.

Authors:  Michael J Silka; Yaniv Bar-Cohen
Journal:  Pediatr Cardiol       Date:  2012-02-07       Impact factor: 1.655

2.  Late arrhythmia in adults with the mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction?

Authors:  M A Gatzoulis; J Walters; P R McLaughlin; N Merchant; G D Webb; P Liu
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

3.  Longitudinal study of ventricular function after the Mustard operation for transposition of the great arteries: a long term follow up.

Authors:  K Y Wong; A W Venables; M J Kelly; V Kalff
Journal:  Br Heart J       Date:  1988-10

Review 4.  [Arrhythmias in patients with congenital heart disease and their impact on prognosis].

Authors:  J Hebe; G Krings; P Hansen; M Volkmer; F Ouyang; K H Kuck
Journal:  Herz       Date:  1999-06       Impact factor: 1.443

5.  Cardiac conduction abnormalities and rhythm changes after neonatal anatomical correction of transposition of the great arteries.

Authors:  S Menahem; M S Ranjit; C Stewart; W J Brawn; R B Mee; J L Wilkinson
Journal:  Br Heart J       Date:  1992-03

Review 6.  Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease.

Authors:  Julia Köbe; Kevin Willy; Lars Eckardt; Helmut Baumgartner; Kristina Wasmer
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 7.  Preventing sudden death in the adult with congenital heart disease.

Authors:  Ronn E Tanel
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

8.  Acceleration of ventricular response to atrial flutter after intravenous adenosine.

Authors:  A C Rankin; A P Rae; A Houston
Journal:  Br Heart J       Date:  1993-03

9.  Results with the Mustard operation in simple transposition of the great arteries 1963-1985.

Authors:  G A Trusler; W G Williams; K F Duncan; P S Hesslein; L N Benson; R M Freedom; T Izukawa; P M Olley
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

10.  [High frequency current ablation of supraventricular tachyarrhythmias in congenital heart defects].

Authors:  J Hebe; M Antz; J Siebels; M Volkmer; F Ouyang; K H Kuck
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.